98 related articles for article (PubMed ID: 21394056)
1. Association between the macular volume and visual acuity was found to be weak.
Chhablani JK; Bartsch DU; Freeman W
Retina; 2011 Apr; 31(4):815; author reply 815-6. PubMed ID: 21394056
[No Abstract] [Full Text] [Related]
2. Correlation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edema.
Blumenkranz MS; Haller JA; Kuppermann BD; Williams GA; Ip M; Davis M; Weinberg DV; Chou C; Whitcup SM
Retina; 2010; 30(7):1090-4. PubMed ID: 20616686
[TBL] [Abstract][Full Text] [Related]
3. INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF REFRACTORY MACULAR EDEMA IN RETINAL VASCULAR DISEASES: Results of the KKESH International Collaborative Retina Study Group.
Alshahrani ST; Dolz-Marco R; Gallego-Pinazo R; Diaz-Llopis M; Arevalo JF;
Retina; 2016 Jan; 36(1):131-6. PubMed ID: 26079477
[TBL] [Abstract][Full Text] [Related]
4. Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion.
Veritti D; Macor S; Lanzetta P
Ophthalmologica; 2014; 232(3):144-8. PubMed ID: 25300393
[TBL] [Abstract][Full Text] [Related]
5. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab versus Dexamethasone Implant Followed by Bevacizumab for the Treatment of Macula Edema Associated with Branch Retinal Vein Occlusion.
Moon SY; Cho KH; Woo SJ; Park SP; Kim YK
Korean J Ophthalmol; 2018 Feb; 32(1):29-37. PubMed ID: 29376223
[TBL] [Abstract][Full Text] [Related]
7. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
[No Abstract] [Full Text] [Related]
8. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients.
Boyer DS; Faber D; Gupta S; Patel SS; Tabandeh H; Li XY; Liu CC; Lou J; Whitcup SM;
Retina; 2011 May; 31(5):915-23. PubMed ID: 21487341
[TBL] [Abstract][Full Text] [Related]
10. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
[TBL] [Abstract][Full Text] [Related]
11. RELATIONSHIP BETWEEN RETINAL THICKNESS AND VISUAL ACUITY IN EYES WITH RETINAL VEIN OCCLUSION TREATED WITH DEXAMETHASONE IMPLANT.
Danis RP; Sadda S; Jiao J; Li XY; Whitcup SM
Retina; 2016 Jun; 36(6):1170-6. PubMed ID: 26655606
[TBL] [Abstract][Full Text] [Related]
12. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
[TBL] [Abstract][Full Text] [Related]
13. Intravitreous dexamethasone effects on different patterns of diabetic macular edema.
Kuppermann BD; Chou C; Weinberg DV; Whitcup SM; Haller JA; Blumenkranz MS;
Arch Ophthalmol; 2010 May; 128(5):642-3. PubMed ID: 20212194
[No Abstract] [Full Text] [Related]
14. Prognostic Factors for Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Dexamethasone Implant.
Lee H; Kang KE; Chung H; Kim HC
Korean J Ophthalmol; 2018 Apr; 32(2):116-125. PubMed ID: 29560616
[TBL] [Abstract][Full Text] [Related]
15. EFFICACY AND SAFETY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR PERSISTENT UVEITIC CYSTOID MACULAR EDEMA.
Khurana RN; Porco TC
Retina; 2015 Aug; 35(8):1640-6. PubMed ID: 25741813
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome.
Mayer WJ; Kurz S; Wolf A; Kook D; Kreutzer T; Kampik A; Priglinger S; Haritoglou C
J Cataract Refract Surg; 2015 Sep; 41(9):1954-61. PubMed ID: 26603404
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal dexamethasone implant for refractory macular edema secondary to vitrectomy for macular pucker.
Furino C; Boscia F; Recchimurzo N; Sborgia C; Alessio G
Retina; 2014 Aug; 34(8):1612-6. PubMed ID: 24752008
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Dexamethasone Implant for the Treatment of Macular Edema in Chronic Non-infectious Uveitis.
Tsang AC; Virgili G; Abtahi M; Gottlieb CC
Ocul Immunol Inflamm; 2017 Oct; 25(5):685-692. PubMed ID: 27191685
[TBL] [Abstract][Full Text] [Related]
19. Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.
Winterhalter S; Vom Brocke GA; Klamann MK; Müller B; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2015 Nov; 253(11):1873-82. PubMed ID: 25576170
[TBL] [Abstract][Full Text] [Related]
20. RETINA.
Retina; 2018 Jun; 38 Suppl 3():1-13. PubMed ID: 29889714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
